SCHEMBL5376808

SCHEMBL5376808

Cc1ccc(S(=O)(=O)Nc2ccc(-c3nnc(C(C)(C)C)o3)cc2)cc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.56
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
HTT P42858 2/20 0.44
LMNA P02545 2/20 0.44
HPGD P15428 5/20 0.43
MAPK1 P28482 3/20 0.43
TP53 P04637 1/20 0.43
NPSR1 Q6W5P4 3/20 0.43
TSHR P16473 2/20 0.43
PTPN5 P54829 2/20 0.43
PKM P14618 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALOX15 P16050 1/20 0.42
HSPD1 P10809 1/20 0.42
HSPE1 P61604 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
GAA P10253 2/20 0.41
WDR5 P61964 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5376622 0.83 PABPC1 (0.57) POLBALDH1A1MAPTHTTLMNA
SCHEMBL5378686 0.82 POLB (0.61) POLBALDH1A1MAPTHTTLMNA
SCHEMBL5376712 0.81 CA1 (0.53) POLBALDH1A1MAPTHTTLMNA
SCHEMBL5378765 0.81 POLB (0.65) POLBALDH1A1MAPTHPGDPTPN5
SCHEMBL5380699 0.79 PTPN2 (0.58) ALDH1A1MAPTHPGDNPSR1PTPN5
SCHEMBL5501882 0.78 POLB (0.70) POLBALDH1A1MAPTHPGDMAPK1
SCHEMBL5380640 0.77 MEN1 (0.57) POLBALDH1A1MAPTHTTLMNA
SCHEMBL5370570 0.77 KDM4E (0.62) ALDH1A1MAPTHPGDNPSR1PTPN5
SCHEMBL5377059 0.76 PTPN5 (0.70) MAPTHPGDPTPN5HSPD1HSPE1
SCHEMBL5373250 0.76 POLB (0.63) POLBMAPTMAPK1ALOX15MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885ALDH1A1 2956/4885MAPT 1786/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885ALDH1A1 2752/4885MAPT 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.